Literature DB >> 9085228

Underlying mechanisms at the bone-surface interface during regeneration.

Z Schwartz1, K Kieswetter, D D Dean, B D Boyan.   

Abstract

The goal of regenerative therapy around teeth and implants is to create a suitable environment in which the natural biological potential for functional regeneration of periodontal ligament and/or bone can be maximized. In order for the regenerative process to be successful, the following factors must be addressed: prevention of acute inflammation from bacteria, mechanical stability of the wound, creation and maintenance of blood clot-filled space, isolation of the regenerative space from undesirable competing tissue types, and the creation of a desirable surface chemistry, energy, roughness and microtopography that can directly influence cellular response, ultimately affecting the rate and quality of new tissue formation and, therefore, the regeneration process. This paper will review how surface characteristics (chemistry and roughness) can affect cell response and local factor production. To evaluate the effect of surface chemistry on cell proliferation and differentiation costochondral chondrocytes were grown on standard tissue culture plastic dishes sputter-coated with different materials. The results indicate that surface materials can elicit differential responses in cell metabolism and phenotypic expression in vitro. In a second study, the effect of varying titanium surface roughnesses on osteoblast-like cell behavior was examined. Surface roughness was found to alter osteoblast proliferation, differentiation and matrix production in vitro. In addition, production of PGE2 and TGF beta by these cells was also shown to increase with increasing surface roughness, indicating that substrate surface roughness also affects cytokine and growth factor production. The role of surface roughness in determining cellular response was further explored by comparing the response of osteoblasts grown on new and previously used surfaces. The results of these latter studies showed that cell proliferation, expression of differentiation markers and overall matrix production are not altered when cells are grown on used vs. virgin surfaces. This suggests the possibility that implants may be re-used, especially in the same patient, if they are appropriately treated. In this context, it should also be noted that rougher titanium surfaces may require more extensive cleaning procedures. From a global perspective, these studies provide some insight into how bone regeneration can be optimized in the presence of an implant or tooth root residing at the site of a bony defect. Since the new bone being produced, during regeneration, grows from a distal area toward the implant or tooth root surface, it is hypothesized that the osteoblasts growing on the surface of the implant may produce local factors that can affect the bone healing process distally. In short, it appears that the surface characteristics of an implant, particularly roughness, may direct tissue healing and, therefore, subsequent implant success in sites of regeneration by modulating osteoblast phenotypic expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085228     DOI: 10.1111/j.1600-0765.1997.tb01399.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  17 in total

1.  The response of osteoblastic MC3T3-E1 cells to micro- and nano-textured, hydrophilic and bioactive titanium surfaces.

Authors:  S Lumetti; E Manfredi; S Ferraris; S Spriano; G Passeri; G Ghiacci; G Macaluso; C Galli
Journal:  J Mater Sci Mater Med       Date:  2016-02-17       Impact factor: 3.896

2.  Role of non-canonical Wnt signaling in osteoblast maturation on microstructured titanium surfaces.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Daphne L Hutton; Ginger R Dunn; Christoph Appert; Barbara D Boyan; Zvi Schwartz
Journal:  Acta Biomater       Date:  2011-02-23       Impact factor: 8.947

3.  A superhydrophilic titanium implant functionalized by ozone gas modulates bone marrow cell and macrophage responses.

Authors:  Riki Toita; Kanji Tsuru; Kunio Ishikawa
Journal:  J Mater Sci Mater Med       Date:  2016-06-25       Impact factor: 3.896

Review 4.  Implant Surface Design Regulates Mesenchymal Stem Cell Differentiation and Maturation.

Authors:  B D Boyan; A Cheng; R Olivares-Navarrete; Z Schwartz
Journal:  Adv Dent Res       Date:  2016-03

5.  Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant.

Authors:  Xiaohua Yu; Liping Wang; Xi Jiang; David Rowe; Mei Wei
Journal:  J Mater Sci Mater Med       Date:  2012-05-26       Impact factor: 3.896

6.  Response of human alveolar bone-derived cells to a novel poly(vinylidene fluoride-trifluoroethylene)/barium titanate membrane.

Authors:  L N Teixeira; G E Crippa; R Gimenes; M A Zaghete; P T de Oliveira; A L Rosa; M M Beloti
Journal:  J Mater Sci Mater Med       Date:  2010-11-24       Impact factor: 3.896

7.  Implant surface treatments affect gene expression of Runx2, osteogenic key marker.

Authors:  Young Na; Seong-Joo Heo; Seong-Kyun Kim; Jai-Young Koak
Journal:  J Adv Prosthodont       Date:  2009-07-31       Impact factor: 1.904

8.  Surface topography modulates the osteogenesis in human bone marrow cell cultures grown on titanium samples prepared by a combination of mechanical and acid treatments.

Authors:  M G Diniz; G A Soares; M J Coelho; M H Fernandes
Journal:  J Mater Sci Mater Med       Date:  2002-04       Impact factor: 3.896

9.  Osseointegration of zirconia implants compared with titanium: an in vivo study.

Authors:  Rita Depprich; Holger Zipprich; Michelle Ommerborn; Christian Naujoks; Hans-Peter Wiesmann; Sirichai Kiattavorncharoen; Hans-Christoph Lauer; Ulrich Meyer; Norbert R Kübler; Jörg Handschel
Journal:  Head Face Med       Date:  2008-12-11       Impact factor: 2.151

10.  Significance of nano- and microtopography for cell-surface interactions in orthopaedic implants.

Authors:  M Jäger; C Zilkens; K Zanger; R Krauspe
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.